Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNon-cash ItemsShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Roivant Sciences (ROIV) Change in Account Payables (2020 - 2025)

Historic Change in Account Payables for Roivant Sciences (ROIV) over the last 6 years, with Q4 2025 value amounting to -$4.0 million.

  • Roivant Sciences' Change in Account Payables rose 7784.81% to -$4.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was -$30.7 million, marking a year-over-year increase of 1028.22%. This contributed to the annual value of -$18.2 million for FY2025, which is 18009.17% down from last year.
  • Latest data reveals that Roivant Sciences reported Change in Account Payables of -$4.0 million as of Q4 2025, which was up 7784.81% from $3.0 million recorded in Q3 2025.
  • In the past 5 years, Roivant Sciences' Change in Account Payables ranged from a high of $62.9 million in Q3 2021 and a low of -$25.3 million during Q2 2024
  • For the 5-year period, Roivant Sciences' Change in Account Payables averaged around $2.9 million, with its median value being $1.8 million (2023).
  • The largest annual percentage gain for Roivant Sciences' Change in Account Payables in the last 5 years was 50100.11% (2024), contrasted with its biggest fall of 110183.64% (2024).
  • Roivant Sciences' Change in Account Payables (Quarter) stood at $3.7 million in 2021, then skyrocketed by 278.28% to $14.0 million in 2022, then crashed by 87.14% to $1.8 million in 2023, then tumbled by 1101.84% to -$18.0 million in 2024, then soared by 77.85% to -$4.0 million in 2025.
  • Its Change in Account Payables was -$4.0 million in Q4 2025, compared to $3.0 million in Q3 2025 and -$11.7 million in Q2 2025.